HistoRx is developing unique diagnostic solutions to unlock new approaches to individualized patient care. HistoRx’s proprietary AQUA® technology uses quantitative IHC to deliver objective and reproducible multiparametric analysis of proteins in routine clinical specimens, providing new insights into cancer treatment. The Company is applying this expertise to build a proprietary pipeline of diagnostic candidates and to help biopharmaceutical customers advance their drug development programs.